Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-based differences in treatment outcome following anticancer drug therapies.

The Lancet. Oncology - 1 Jan 2010

Ma Brigette By, Hui Edwin P, Mok Tony Sk

Abstract excerpt

Population-based differences in toxicity and clinical outcome following treatment with anticancer drugs have an important effect on oncology practice and drug development. These differences arise from complex interactions between biological and environmental factors, which include genetic diversity affecting drug metabolism and the expression of drug targets, variations in tumour biology and host physiology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Environment
Share to Patient Selection

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Precision Medicine

Share to Racial Groups

Share to Risk Assessment

Share to Stomach Neoplasms

Source

Identifiers

PMID: 20129130
DOI: 10.1016/S1470-2045(09)70160-3

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-based differences in treatment outcome following anticancer drug therapies.PMID 20129130Read ↗

Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape?Semantic proximity Read ↗

The role of pharmacoethnicity in the development of cytotoxic and molecular targeted drugs in oncology.Semantic proximity Read ↗

Can population differences in chemotherapy outcomes be inferred from differences in pharmacogenetic frequencies?Semantic proximity Read ↗

Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related PharmacogenomicsSemantic proximity Read ↗

Host - Tumor Determinants of Chemotherapy Toxicity and Resistance in the Postoperative Management of Geriatric Colorectal Cancer: A Mechanistic Scoping ReviewSemantic proximity Read ↗

Ethnic differences in drug metabolism and toxicity from chemotherapy.Semantic proximity Read ↗

Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.Semantic proximity Read ↗

Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.Semantic proximity Read ↗

Efflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysis.Semantic proximity Read ↗

Pharmacokinetics and pharmacogenomics in esophageal cancer chemoradiotherapy.Semantic proximity Read ↗

Part 4: pharmacogenetic variability in anticancer pharmacodynamic drug effects.Semantic proximity Read ↗

Emerging ethnic differences in lung cancer therapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.